Comparative Study
Determination of carcinogenic arylamine N-oxidation phenotype in humans by analysis of caffeine urinary metabolites
Affiliations
- PMID: 2392442
Item in Clipboard
Comparative Study
Determination of carcinogenic arylamine N-oxidation phenotype in humans by analysis of caffeine urinary metabolites
Prog Clin Biol Res.
1990.
No abstract available
Similar articles
-
Analysis of within-subject variation of caffeine metabolism when used to determine cytochrome P4501A2 and N-acetyltransferase-2 activities.Cancer Epidemiol Biomarkers Prev. 1995 Mar;4(2):139-46. Cancer Epidemiol Biomarkers Prev. 1995. PMID: 7742721
-
Acetylator phenotyping: the urinary caffeine metabolite ratio in slow acetylators correlates with a marker of systemic NAT1 activity.Pharmacogenetics. 1994 Jun;4(3):166-70. Pharmacogenetics. 1994. PMID: 7920698
-
Segregation analyses of four urinary caffeine metabolite ratios implicated in the determination of human acetylation phenotypes.Genet Epidemiol. 1994;11(2):115-29. doi: 10.1002/gepi.1370110203. Genet Epidemiol. 1994. PMID: 8013893
-
Acetylator status, drug metabolism and disease.Natl Med J India. 2003 Jan-Feb;16(1):24-6. Natl Med J India. 2003. PMID: 12715953 Review.
-
Review of studies of selected metabolic polymorphisms and cancer.IARC Sci Publ. 1999;(148):323-93. IARC Sci Publ. 1999. PMID: 10493265 Review. No abstract available.
Cited by
-
A population and family study of CYP1A2 using caffeine urinary metabolites.Eur J Clin Pharmacol. 1995;47(5):423-30. doi: 10.1007/BF00196856. Eur J Clin Pharmacol. 1995. PMID: 7720764
-
Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct.Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5350-4. doi: 10.1073/pnas.88.12.5350. Proc Natl Acad Sci U S A. 1991. PMID: 2052611 Free PMC article.
-
Clinically significant pharmacokinetic interactions between dietary caffeine and medications.Clin Pharmacokinet. 2000 Aug;39(2):127-53. doi: 10.2165/00003088-200039020-00004. Clin Pharmacokinet. 2000. PMID: 10976659 Review.
-
Comparison of CYP1A2 and NAT2 phenotypes between black and white smokers.Biochem Pharmacol. 2008 Oct 1;76(7):929-37. doi: 10.1016/j.bcp.2008.07.024. Epub 2008 Jul 25. Biochem Pharmacol. 2008. PMID: 18703023 Free PMC article. Clinical Trial.
-
Caffeine as a metabolic probe: a comparison of the metabolic ratios used to assess CYP1A2 activity.Br J Clin Pharmacol. 1995 Jan;39(1):65-9. doi: 10.1111/j.1365-2125.1995.tb04411.x. Br J Clin Pharmacol. 1995. PMID: 7756101 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical